Tibet Weixinkang Medicine Co., Ltd. (SHA:603676)
China
· Delayed Price · Currency is CNY 11.04
+0.24 (2.22%)
At close: Mar 10, 2026
Tibet Weixinkang Medicine Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Net Income | 222.08 | 246.17 | 214.02 | 176.96 | 95.91 | 58.42 | Upgrade
|
| Depreciation & Amortization | 52.89 | 52.89 | 48.57 | 40.93 | 34.09 | 31.08 | Upgrade
|
| Other Amortization | 8.38 | 8.38 | 1.78 | 12.03 | 2.07 | 1.75 | Upgrade
|
| Loss (Gain) From Sale of Assets | -0.01 | -0.01 | 0.44 | -0.16 | -0.06 | 0.02 | Upgrade
|
| Asset Writedown & Restructuring Costs | 17.63 | 17.63 | 0.13 | 14.16 | 3.25 | 1.17 | Upgrade
|
| Loss (Gain) From Sale of Investments | -20.34 | -20.34 | -24.42 | -15.76 | -11.32 | -13.49 | Upgrade
|
| Provision & Write-off of Bad Debts | -0.33 | -0.33 | -2.13 | 0.23 | -1.55 | -1.22 | Upgrade
|
| Other Operating Activities | -150.7 | 3.22 | 1.4 | -0.52 | 5.23 | -0.45 | Upgrade
|
| Change in Accounts Receivable | 13.11 | 13.11 | 34.56 | -25.4 | 24.4 | 61.25 | Upgrade
|
| Change in Inventory | -6.32 | -6.32 | -6.5 | -9.17 | -3.3 | -8.64 | Upgrade
|
| Change in Accounts Payable | 42.08 | 42.08 | -7.42 | 49.08 | -1.44 | -0.17 | Upgrade
|
| Change in Other Net Operating Assets | 3.68 | 3.68 | 4.43 | 21.38 | 20.7 | 1.85 | Upgrade
|
| Operating Cash Flow | 194.78 | 372.78 | 241.12 | 246.15 | 170.69 | 133.7 | Upgrade
|
| Operating Cash Flow Growth | -47.43% | 54.61% | -2.05% | 44.21% | 27.67% | 25.73% | Upgrade
|
| Capital Expenditures | -71.84 | -58.18 | -70.81 | -77.69 | -55.6 | -54.35 | Upgrade
|
| Sale of Property, Plant & Equipment | 0 | - | 0.05 | 0.22 | 0.32 | 0.04 | Upgrade
|
| Investment in Securities | -170.5 | -174.92 | -334.01 | 166.89 | -110.19 | -14.6 | Upgrade
|
| Other Investing Activities | 296.42 | 23.14 | 15.56 | 15.8 | 12.75 | 14.09 | Upgrade
|
| Investing Cash Flow | 54.08 | -209.96 | -389.21 | 105.21 | -152.71 | -54.82 | Upgrade
|
| Long-Term Debt Repaid | - | -9.56 | -4.6 | -3.99 | -6.15 | - | Upgrade
|
| Net Debt Issued (Repaid) | -9.56 | -9.56 | -4.6 | -3.99 | -6.15 | - | Upgrade
|
| Issuance of Common Stock | - | - | - | - | 53.32 | - | Upgrade
|
| Repurchase of Common Stock | -30 | -30 | - | -3.17 | -0.44 | - | Upgrade
|
| Common Dividends Paid | -157.81 | -177.85 | -97.84 | -68.66 | -40.19 | -19.04 | Upgrade
|
| Other Financing Activities | 5.19 | - | - | - | -0.27 | - | Upgrade
|
| Financing Cash Flow | -192.18 | -217.4 | -102.44 | -75.82 | 6.27 | -19.04 | Upgrade
|
| Foreign Exchange Rate Adjustments | 0.6 | 0.49 | 0.63 | - | - | - | Upgrade
|
| Net Cash Flow | 57.28 | -54.09 | -249.9 | 275.55 | 24.25 | 59.84 | Upgrade
|
| Free Cash Flow | 122.94 | 314.61 | 170.3 | 168.46 | 115.09 | 79.35 | Upgrade
|
| Free Cash Flow Growth | -60.96% | 84.73% | 1.09% | 46.37% | 45.04% | 26.58% | Upgrade
|
| Free Cash Flow Margin | 10.52% | 24.20% | 12.88% | 12.04% | 11.13% | 11.09% | Upgrade
|
| Free Cash Flow Per Share | 0.29 | 0.73 | 0.40 | 0.39 | 0.28 | 0.19 | Upgrade
|
| Cash Income Tax Paid | 117.56 | 116.9 | 139.38 | 132.85 | 104.32 | 59.26 | Upgrade
|
| Levered Free Cash Flow | 51.33 | 184.29 | 84.69 | 51.84 | 128.62 | 54.65 | Upgrade
|
| Unlevered Free Cash Flow | 51.45 | 184.43 | 84.9 | 51.95 | 128.7 | 54.65 | Upgrade
|
| Change in Working Capital | 65.17 | 65.17 | 1.33 | 18.27 | 43.07 | 56.42 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.